Share on StockTwits

Merge Healthcare (NASDAQ:MRGE) Director William J. Devers, Jr. acquired 100,000 shares of the company’s stock on the open market in a transaction dated Monday, May 19th. The stock was purchased at an average cost of $2.07 per share, for a total transaction of $207,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Merge Healthcare (NASDAQ:MRGE) traded up 0.94% on Tuesday, hitting $2.14. The stock had a trading volume of 339,124 shares. Merge Healthcare has a one year low of $1.97 and a one year high of $4.71. The stock has a 50-day moving average of $2.32 and a 200-day moving average of $2.3. The company’s market cap is $202.7 million.

Merge Healthcare (NASDAQ:MRGE) last released its earnings data on Wednesday, April 30th. The company reported $0.04 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.04. The company had revenue of $50.90 million for the quarter, compared to the consensus estimate of $52.49 million. During the same quarter in the previous year, the company posted ($0.01) earnings per share. The company’s revenue for the quarter was down 20.0% on a year-over-year basis. Analysts expect that Merge Healthcare will post $0.10 EPS for the current fiscal year.

Separately, analysts at Zacks downgraded shares of Merge Healthcare from a “neutral” rating to an “underperform” rating in a research note on Monday, March 24th. They now have a $2.25 price target on the stock.

Merge Healthcare Incorporated (NASDAQ:MRGE) develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.